HK1115636A1 - Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1 - Google Patents

Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1

Info

Publication number
HK1115636A1
HK1115636A1 HK08106060.4A HK08106060A HK1115636A1 HK 1115636 A1 HK1115636 A1 HK 1115636A1 HK 08106060 A HK08106060 A HK 08106060A HK 1115636 A1 HK1115636 A1 HK 1115636A1
Authority
HK
Hong Kong
Prior art keywords
cyfra
colorectal cancer
marker
assessment
relates
Prior art date
Application number
HK08106060.4A
Other languages
English (en)
Inventor
Johann Karl
Herbert Andres
Veit Grunert
Wolfgang Rollinger
Werner Zolg
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1115636A1 publication Critical patent/HK1115636A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK08106060.4A 2004-12-23 2008-05-30 Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1 HK1115636A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04030619 2004-12-23
PCT/EP2005/013867 WO2006066915A1 (en) 2004-12-23 2005-12-22 Use of cyfra 21-1 as a marker for colorectal cancer

Publications (1)

Publication Number Publication Date
HK1115636A1 true HK1115636A1 (en) 2008-12-05

Family

ID=34927964

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08106060.4A HK1115636A1 (en) 2004-12-23 2008-05-30 Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1

Country Status (10)

Country Link
US (1) US7731938B2 (de)
EP (1) EP1831695B1 (de)
JP (1) JP4606469B2 (de)
CN (2) CN101088012A (de)
AT (1) ATE430936T1 (de)
CA (1) CA2585788C (de)
DE (1) DE602005014386D1 (de)
ES (1) ES2325277T3 (de)
HK (1) HK1115636A1 (de)
WO (1) WO2006066915A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2059813A2 (de) * 2006-06-26 2009-05-20 Technion Research & Development Foundation LTD. Verfahren und kits zur krebsdiagnose
WO2008014951A1 (en) * 2006-08-01 2008-02-07 Roche Diagnostics Gmbh Use of nnmt as a marker for lung cancer
US20100196889A1 (en) * 2006-11-13 2010-08-05 Bankaitis-Davis Danute M Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer
EP2223116B1 (de) * 2007-12-10 2014-11-19 Roche Diagnostics GmbH Markerpanel für kolorektalkrebs
WO2010000467A1 (en) 2008-07-03 2010-01-07 F. Hoffmann-La Roche Ag Asc as a marker for lung cancer
US9075060B2 (en) * 2009-06-16 2015-07-07 Technion Research & Development Foundation Limited Methods for diagnosing oral or oral-pharyngeal cancer
US20130095503A1 (en) * 2010-01-05 2013-04-18 University Of Cincinnati Serum spla2-iia as diagnosis marker for prostate and lung cancer
WO2012031374A1 (zh) 2010-09-09 2012-03-15 北京同为时代生物技术有限公司 用于诊断上皮源性癌症的血液标志物及其单克隆抗体
CN103403555B (zh) * 2011-03-11 2015-06-24 霍夫曼-拉罗奇有限公司 Asc作为慢性阻塞性肺病(copd)的标志物
WO2013160807A1 (en) * 2012-04-24 2013-10-31 Sahillioglu Ali Can A method for antigen delivery
KR101619122B1 (ko) 2013-08-14 2016-05-10 연세대학교 산학협력단 탈메틸화 의존적 ａｓｃ 발현을 촉진시켜서 대장암 종양세포의 사멸감수성을 증진시키는 항암제 병용 투여용 후보물질의 스크리닝 방법
JP6750140B2 (ja) * 2014-08-22 2020-09-02 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 直腸結腸がんを早期検出するための方法
US20200339670A1 (en) * 2017-12-20 2020-10-29 Michael Heneka Novel means and methods for treating neurodegenerative diseases
KR102293271B1 (ko) * 2019-02-25 2021-08-23 가톨릭대학교 산학협력단 Cyfra 21-1을 이용한 갑상선암 림프절 전이 진단 방법
JP2022522803A (ja) * 2019-03-01 2022-04-20 アドバンスド マーカー ディスカバリー エセ． エレ． 結腸直腸癌及び／又はその前癌段階の診断用タンパク質シグネチャー
EP4121767A1 (de) * 2020-03-19 2023-01-25 Advanced Marker Discovery, S.L. Proteinsignatur zum screening einer allgemeinen population auf kolorektalkarzinom und/oder dessen präkanzerogene stufe

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165740A (en) * 1998-09-30 2000-12-26 Sysmex Corporation Method and device for flow-cytometric microorganism analysis
US7118912B2 (en) * 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
US20040157278A1 (en) * 2002-12-13 2004-08-12 Bayer Corporation Detection methods using TIMP 1
AU2003296684A1 (en) * 2002-12-20 2004-07-14 F. Hoffmann-La Roche Ag Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
ATE353544T1 (de) * 2003-05-26 2006-09-15 Hoffmann La Roche Verwendung des proteins masp als marker für kolorektale karzinome

Also Published As

Publication number Publication date
CN101088012A (zh) 2007-12-12
DE602005014386D1 (de) 2009-06-18
CN101088011B (zh) 2012-07-18
EP1831695B1 (de) 2009-05-06
US20080020414A1 (en) 2008-01-24
US7731938B2 (en) 2010-06-08
ATE430936T1 (de) 2009-05-15
CN101088011A (zh) 2007-12-12
CA2585788A1 (en) 2006-06-29
EP1831695A1 (de) 2007-09-12
JP4606469B2 (ja) 2011-01-05
ES2325277T3 (es) 2009-08-31
WO2006066915A1 (en) 2006-06-29
JP2008522172A (ja) 2008-06-26
CA2585788C (en) 2013-03-05

Similar Documents

Publication Publication Date Title
HK1115636A1 (en) Use of cyfra 21-1 as a marker for colorectal cancer cyfra 21-1
ATE554389T1 (de) Apex als marker für lungenkrebs
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
SG10201408392PA (en) Methods of determining patient response by measurement of her-3
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
WO2008070865A3 (en) Materials and methods for efficient and accurate detection of analytes
EP3575781A3 (de) Teststreifen und verfahren zum ablesen von teststreifen
HK1136873A1 (en) Use of nnmt as a marker for lung cancer
WO2010136163A8 (en) Secernin-1 as a marker for cancer
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
EP1930445A4 (de) Kit und verfahren zum nachweis von urothelkarzinom
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
WO2010000467A8 (en) Asc as a marker for lung cancer
MX341181B (es) Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta.
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
WO2010130839A4 (en) Cybp as a marker of lung cancer
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
CY1121482T1 (el) Ευαισθητη πολυπλεκτικη ανοσοδοκιμασια για τους διαλυτους υποδοχεις των αυξητικων παραγοντων των ινοβλαστων
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs
ATE359516T1 (de) Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs
WO2004071267A3 (en) Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample
EP1995595A4 (de) Verfahren zur bewertung des hautempfindlichkeitsniveaus durch verwendung von mit plattenepithelkarzinom zusammenhängendem antigen als indikation
ATE410691T1 (de) Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20211221